We emphasize that our data do not exclude the possibility that other adverse effects (including increased cell death [Eizirik et al., 2008] and mitochondrial uncoupling [Joseph et al., 2004]) ultimately develop during protracted hyperlipidemia and contribute to the impaired insulin release. The gene discussed is INS; the disease is hyperlipidemia.